| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C0010992> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C0018704> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C0022277> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C0036232> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34043934_HAS_TOPIC_C5398043>
?:authorAffiliation	[\'Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences L. Sacco, \'Luigi Sacco\' University Hospital, Università di Milano, Milan, Italy.\', \'Scientific Institute IRCCS E. Medea, Bosisio Parini, LC, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Battini_Vera> <https://research.tib.eu/covid-19/entity/Cammarata_Gianluca> <https://research.tib.eu/covid-19/entity/Carnovale_Carla> <https://research.tib.eu/covid-19/entity/Clementi_Emilio> <https://research.tib.eu/covid-19/entity/Gringeri_Michele> <https://research.tib.eu/covid-19/entity/Guarnieri_Greta> <https://research.tib.eu/covid-19/entity/Mosini_Giulia> <https://research.tib.eu/covid-19/entity/Radice_Sonia>
?:doi	10.1080/21645515.2021.1917236
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/21645515.2021.1917236>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Human vaccines & immunotherapeutics
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34043934>
?:pmid	<https://research.tib.eu/covid-19/entity/34043934>
?:pmid	34043934
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34043934>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34043934>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all